Mexitil

Active Ingredient(s): Mexiletine
FDA Approved: * December 30, 1985
Pharm Company: * BOEHRINGER INGELHEIM
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mexitil Overview

Mexiletine (INN) (sold under the trade names Mexitil and NaMuscla) is a drug used to treat abnormal heart rhythms, chronic pain, and some causes of muscle stiffness. Common side effects include abdominal pain, chest discomfort, drowsiness, headache, and nausea. It works as a non-selective voltage-gated sodium channel blocker and belongs to the Class IB group of anti-arrhythmic medications.[1] Contents 1 Medical uses 2 Adverse effects 3 Pharmacology 4 Synthesis 5 Society...

Read more Mexitil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mexiletine

Recent Mexitil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mexiletine
  • Capsule: 150mg, 200mg, 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Mexiletine or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA